Last reviewed · How we verify

NCT04648072: TRUE KnORTH

How Does the Addition of Adductor Canal Block to Local Infiltration Affect Recovery in Patients Undergoing Total Knee Arthroplasty? A Feasibility Study.

Completed NA Last updated 6 May 2023
What this trial tests

NA trial testing Adductor Canal Block in Knee Osteoarthritis in 60 participants. Completed in 1 December 2021.

Timeline
4 November 2020
Primary endpoint
30 November 2021
1 December 2021

Quick facts

Lead sponsorHealth Sciences North Research Institute
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposetreatment
Enrollment60
Start date4 November 2020
Primary completion30 November 2021
Estimated completion1 December 2021
Sites1 location across Canada

Drugs / interventions tested

Conditions studied

Sponsor

Health Sciences North Research Institute

Who can join

18 and older, any sex, with Knee Osteoarthritis or Arthritis Knee. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The use of periarticular injection and adductor canal block are well-established techniques used both in combination or in isolation in the management of postoperative pain for patients undergoing total knee arthroplasty. The aim of this study is to investigate whether combining these two techniques have an added benefit, compared to periarticular injection alone, with respect to quality of recovery, functional return, discharge readiness, and short and long term post-operative narcotic use.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Adductor Canal Block

Trials testing the same drug.

Other recruiting trials for Knee Osteoarthritis

Currently open trials in the same condition.

Other Health Sciences North Research Institute trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04648072.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing